NESQUIK Recall Issued Over Salmonella Risk

About 200,000 cans of NESQUIK chocolate drink powder have been recalled after Nestle was notified that a certain ingredient may be contaminated with Salmonella, posing a potential health risk for consumers.

The Nestle NESQUICK Chocolate Powder recall was announced by the FDA on November 8, after it was discovered that salmonella may be present in an ingredient.

Omya Inc., the ingredient supplier, informed Nestle that the calcium carbonate used in the powder tested positive for salmonella in a random sample check. However, there have been no reported cases of salmonella food poisoning connected to the recalled NESQUIK cannisters.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

The recall includes NESQUIK chocolate powder sold in canister sizes of 10.9 oz. Chocolate (19 serving) with UPC Code 0 28000 68230 9, 21.8 Chocolate (38 servings) with UPC Code 028000 68090 9, and 40.7 oz. Chocolate (72 servings) with UPC Code 0 28000 68230 9.

Affected NESQUIK Chocolate Powder has any of the following production codes located on the bottom of the canisters: 2278574810, 2278574820, 2279574810, 2279574820, 2284574820, 2284574830, 2285574810, 2285574820, 2287574820, 2289574810, 2289574820, 2278574810, 2282574810, and 2282574820.

Affected canisters were produced during early October 2012 and were shipped across the nation with an expiration date of BEST BEFORE October 2014.

Salmonella can cause symptoms that consist of fever, diarrhea, nausea, vomiting, and abdominal pain, which typically resolve in a few days or weeks for healthy individuals. However, if the bacterium enters the blood stream, it can cause more severe side effects such as infected aneurysms, endocarditis, arthritis, and sometimes fatal infections in young children or elderly people.

No injuries or adverse health consequences have been reported but Nestle’ has removed all of the affected products from store shelves and is asking for consumers to stop using the recalled chocolate powder immediately.

Consumers who purchased affected powder should not consume it and should return it to the place of purchase for a full refund. Consumers with questions can call Nestle Consumer Services at (800) 628.7679.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits
Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits (Posted yesterday)

A federal judge has agreed to divide lawsuits over gastroparesis injuries linked to drugs like Ozempic and Mounjaro into multiple phases, examining how the condition is diagnosed and whether plaintiffs' claims are preempted by federal laws.

Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn
Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn (Posted 3 days ago)

Lawsuit alleges that Abbott Laboratories failed to provide families and the medical community with adequate warnings about the risks associated with it’s cow’s milk-based Similac formula, which a now adult woman indicates has left her with life-long NEC injuries.

Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects
Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects (Posted 4 days ago)

Six breast cancer patients have asked a federal judge for permission to amend a complaint filed in March 2024, which describes problems linked to the device and painful side effects experienced when the tissue marker migrated out of position or shattered inside their bodies.